Drug Trial Radar · NCT00589992
Ibutilide Administration During Pulmonary Vein Ablation
Last checked: Nov 19, 2026Latest source record: Jan 31, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
50
Planned (sponsor's estimate)
Start
Oct 2007
Primary completion
Dec 2015
Study completion Dec 2016
Sponsor
- Lead sponsor
- Ball Memorial HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Abbott Medical Devices
- First posted
- Jan 10, 2008
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Basic science
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To test the hypothesis that localized functional reentry maintains Afib in humans, ibutilide will be administered intravenously in patients undergoing an Afib ablation. The hypothesis of this study is that ibutilide will decrease the high frequency signals observed in Afib suggesting the presence of micro reentrant circuits as the basic mechanism of Afib, especially for the paroxysmal Afib group. The potential difference in response to the ibutilide in patients with paroxysmal versus persistent Afib may show the difference in the underlying mechanism of Afib between these two groups.
Conditions
- Atrial Fibrillation
- Pulmonary Vein Ablation
Interventions
Ibutilide fumarateDrug
During scheduled radio frequency ablation for atrial fibrillation patients will be infused with 1mg of ibutilide over 10 minutes.
Primary outcomes
What the sponsor says the trial is designed to measure.
- To discern the basic mechanism of Afib by studying its response to Ibutilide administration.Time frame: one year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Medical Consultants, P.C.
Muncie, Indiana · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.